Currently, a limited number of effective therapeutics for AD are available, and only a few drugs have been approved by the FDA as AD treatments, such as acetylcholinesterase (AChE) inhibitors and the N-methyl-D-aspartate receptor antagonist memantine [3, 4]. Here, ACHE is linked to Alzheimer disease.